Consider a GLP-1 Agonist for Diabetic Patients on 2 or 3 Oral Meds

August 2014

Tanzeum (TAN-zee-um, albiglutide) will be another GLP-1 agonist for diabetes...after Byetta, Victoza, and Bydureon.

These injectables will continue to gain popularity because they cause weight loss...and are unlikely to cause hypoglycemia.

Pick one based on their pros and cons...and patient preference.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote